Bank of New York Mellon »

Protalix Biotherapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $218k 173k 1.26
2023-12-31 $318k 179k 1.78
2023-09-30 $275k 166k 1.66
2023-06-30 $294k 147k 2.00